ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

Rhea-AI Summary

ANI Pharmaceuticals (ANIP) has announced its participation in the upcoming 2025 RBC Capital Markets Ophthalmology Virtual Conference. The company's President and CEO, Nikhil Lalwani, will conduct a fireside chat during the event.

The presentation will be available through a live and archived webcast on the company's website www.anipharmaceuticals.com under the Investors section's Events and Presentations area. Interested parties can access the webcast replay for 60 days following the event.

News Market Reaction – ANIP

+1.60%

+1.60% Session move

In the trading session that priced this news, ANIP gained 1.60%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PRINCETON, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, will host a fireside chat at the 2025 RBC Capital Markets Ophthalmology Virtual Conference as follows:

Date:	Thursday, April 3, 2025
Time:	7:45am ET
Webcast:	Click here

The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 60 days.

About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit www.anipharmaceuticals.com.

Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

Source: ANI Pharmaceuticals, Inc.

FAQ

When is ANI Pharmaceuticals (ANIP) presenting at the RBC Capital Markets Ophthalmology Conference 2025?

ANI Pharmaceuticals will present at the RBC Capital Markets Ophthalmology Virtual Conference in 2025, with CEO Nikhil Lalwani hosting a fireside chat.

How long will ANIP's RBC Conference presentation webcast be available for replay?

The webcast replay will be available for 60 days on ANI Pharmaceuticals' website.

Where can investors access ANIP's 2025 RBC Conference presentation webcast?

The webcast will be available at www.anipharmaceuticals.com under the Investors section's Events and Presentations area.

Who will represent ANIP at the 2025 RBC Ophthalmology Conference?

Nikhil Lalwani, President and Chief Executive Officer of ANI Pharmaceuticals, will represent the company.